Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTyratech Regulatory News (TYR)

  • There is currently no data for TYR

Appointment

17 Mar 2008 07:02

TyraTech, Inc.17 March 2008 For immediate release 17 March 2008 TyraTech Inc. ("TyraTech" or "the Company") TyraTech Appoints Sr. Director Business Development Kim Watson to Expand Global Partnerships for Clean Pesticide and Animal Health Company TyraTech Inc (AIM: TYR), a pioneer of safer, effective and natural activeingredients for the pesticide, animal health and human functional food markets,announces today the appointment of Kim Watson as Senior Director BusinessDevelopment. Watson will identify new commercial development partnerships andmarket opportunities to expand TyraTech's traction in the internationalinstitutional, agricultural, consumer, and animal and public health markets. Inthe newly created position, Watson will report to Stephen Briggs, Vice PresidentGlobal Markets. "TyraTech's growing line of active ingredient components for extremelyeffective products for the entire invertebrate pest control spectrum haspositioned the Company for numerous commercial opportunities. In order tocapitalise on the breadth and strength of our proprietary technology, we arecurrently pursuing an aggressive growth strategy of major industry partnershipsand licensing," said R. Douglas Armstrong, Ph.D., CEO of TyraTech. "Aninvaluable addition to our team, Watson brings specific experience in realisingboth new market opportunities as well as paths to market through industrycollaboration and partnership." Watson has more than 20 years of experience in discovering, developing andcommercialising new technologies in the agricultural chemical industry. Prior tojoining TyraTech, Watson served as director of product acquisitions andlicensing at FMC Corporation, a worldwide, diversified chemical companyheadquartered in Philadelphia. While at FMC, he was responsible for driving newbusiness growth through acquisitions or licensing and secured exclusive accessto several platform technologies. He also spent several years working withBayer Australia, where he was a technical development officer and responsiblefor the marketing and distribution of proprietary agricultural chemicals. Watsonis an active member in industry associations, including the Licensing ExecutivesSociety, and holds 18 technology patents of his own. Steve Briggs added, "The Company has seen a material increase in commercial anddevelopment capability following recent key appointments, which havecomplemented our already strong research and technology development resources".The addition of Mr. Watson complements other recent commercial market teamadditions at TyraTech which have included Dr. Peter Porpiglia, joining TyraTechfrom Kumiai Chemical as Sr. Director Product Development, and William Baxter,who moved from BASF as Sr. Director Market Development. For further information please contact: TyraTech Inc. +1 (321) 409 7403Douglas Armstrong PhD, Chief Executive Officerwww.tyratech.com Buchanan Communications +44 (0) 20 7466 5000Mary-Jane Johnson) / Lisa Baderoon / Catherine Breenwww.buchanan.uk.com About TyraTech, Inc. TyraTech is pioneering a new class of highly effective, non-toxic, pesticidesand anti-parasitic compounds to address global agriculture, horticulture,functional foods, healthcare and veterinary markets. Using a revolutionarychemoreceptor screening process, TyraTech has identified proprietary blends ofnatural oils that stimulate the reactions and biological behaviour of insectsand parasites so that they can be effectively repelled or killed. TyraTech'stechnology avoids the environmental concerns and human health risks as well asthe development of resistance that are both associated with chemical pesticides,while still providing highly potent efficacy. The Company's products have been validated through strong partnerships withmultinational conglomerates operating within a growing US$23 billion worldwidemarket that is being increasingly driven by environmental legislation andend-user demand. TyraTech continues to develop new product applications based on safe, naturalingredients with a broad range of partners around the world. www.tyratech.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
29th Sep 20107:00 amRNSInterim Results
9th Sep 20109:46 amRNSNotice of Interim Results
25th Aug 20104:50 pmRNSUnrestricted Trading Line Completed
5th Aug 20107:00 amRNSBoard Change
29th Jul 20102:40 pmRNSMajor Interest in Shares
19th Jul 20107:00 amRNSEstablishing Unrestricted Trading Line
9th Jul 201012:41 pmRNSResult of AGM and Board Changes
23rd Jun 20104:06 pmRNSMajor Interest in Shares
22nd Jun 20107:00 amRNSResults for the year ended 31 December 2009
21st May 20105:35 pmRNSDirectors' Disclosure
19th May 20105:15 pmRNSResult of Special Meeting
18th May 20107:00 amRNSUpdate to Fundraising
10th May 20107:00 amRNSFundraising and Trading Update
29th Apr 20107:00 amRNSProspective fundraising of approximately £1m
24th Feb 20107:00 amRNSPreliminary Results
4th Feb 20105:41 pmRNSAward of Share Options
4th Feb 20107:00 amRNSExpanded Terminix Agreement
5th Jan 20107:00 amRNSBoard Changes
24th Nov 20097:00 amRNSTrading Update
11th Nov 20097:00 amRNSDirector Share Purchase
9th Nov 20097:00 amRNSArysta Insecticide Product Launch
5th Oct 20097:00 amRNSKraft Milestone and Contract
21st Sep 20093:41 pmRNSDirector Share Purchase
16th Sep 20097:01 amRNSBoard Changes
16th Sep 20097:01 amRNSChange of Auditor
16th Sep 20097:00 amRNSInterim Results
10th Sep 20097:00 amRNSClarke Partnership
19th Aug 20097:00 amRNSStrategic Partnership Agreement
28th Jul 20097:00 amRNSNew Product Launch
23rd Jul 20097:00 amRNSTrading Update
22nd Jun 20092:03 pmRNSAnnual Report and Accounts
21st May 200912:15 pmRNSAGM Statement
20th May 20097:00 amRNSExpanded Agreement with Terminix
20th Apr 20097:00 amRNSTerminix First Shipment
16th Apr 20096:02 pmRNSDirectors Share Purchase
15th Apr 20096:20 pmRNSDIRECTORS SHARE PURCHASE
14th Apr 20095:44 pmRNSDirectors Share Purchase
9th Apr 20095:17 pmRNSDirector Share Dealings
7th Apr 20095:00 pmRNSCorrected Notice of AGM
1st Apr 20097:06 amRNSPreliminary Results
30th Mar 20097:00 amRNSNew product Launches
20th Mar 20097:00 amRNSNotice of Preliminary Results
27th Jan 20097:00 amRNSShare Buy Back Transaction
16th Jan 20097:04 amRNSOptions Award
16th Jan 20097:02 amRNSShare Buy Back
16th Jan 20097:00 amRNSSalary Reductions
14th Jan 20097:00 amRNSNew Joint Venture - TyraChem
23rd Dec 20087:00 amRNSProgress with Kraft Foods Partnership
24th Nov 20087:00 amRNSAgreement Signed with Terminix
20th Oct 20087:00 amRNSSummons from Molecular Securities, Inc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.